Ergotamine/caffeine treatment of orthostatic hypotension in parkinsonism with autonomic failure

被引:15
|
作者
Dewey, RB
Rao, SD
Holmburg, SL
Victor, RG
机构
[1] Univ Texas, SW Med Ctr, Dept Neurol, Dallas, TX 75235 USA
[2] Univ Texas, SW Med Ctr, Dept Internal Med, Div Hypertens, Dallas, TX 75235 USA
关键词
parkinsonism; Shy-Drager syndrome; autonomic failure; ergotamine; orthostatic hypotension;
D O I
10.1046/j.1468-1331.1998.560593.x
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Eight patients with parkinsonism who developed severe orthostatic hypotension, were treated with oral ergotamine/caffeine. Significant long-term improvement in standing systolic blood pressure and symptoms of syncope and lightheadedness were observed in four of these patients. One patient in whom the drug was effective discontinued it because of nausea. Another lost benefit after 2 weeks of successful therapy. Significant supine systolic hypertension occurred in only one patient, which was easily managed by nifedipine given at night. Symptoms or signs of ergotism were not observed. Oral ergotamine/caffeine should be considered as a cost-effective treatment for refractory orthostatic hypotension in carefully selected patients with parkinsonism. Eur J Neurol 5:593-599 (C) 1998 Lippincott Williams & Wilkins.
引用
收藏
页码:593 / 599
页数:7
相关论文
共 50 条
  • [21] Treatment of Patients with Neurogenic Orthostatic Hypotension
    Simona Maule
    Mirko Tredici
    Sara Del Colle
    Livio Chiandussi
    High Blood Pressure & Cardiovascular Prevention, 2003, 10 (2) : 95 - 103
  • [22] Autoregulatory cerebral vasodilation occurs during orthostatic hypotension in patients with primary autonomic failure
    Horowitz, DR
    Kaufmann, H
    CLINICAL AUTONOMIC RESEARCH, 2001, 11 (06) : 363 - 367
  • [23] Current pharmacologic treatment for orthostatic hypotension
    Roy Freeman
    Clinical Autonomic Research, 2008, 18 : 14 - 18
  • [24] Autoregulatory cerebral vasodilation occurs during orthostatic hypotension in patients with primary autonomic failure
    Deborah R. Horowitz
    Horacio Kaufmann
    Clinical Autonomic Research, 2001, 11 : 363 - 367
  • [25] New trends in the treatment of orthostatic hypotension
    Jordan J.
    Current Hypertension Reports, 2001, 3 (3) : 216 - 224
  • [26] Current pharmacologic treatment for orthostatic hypotension
    Freeman, Roy
    CLINICAL AUTONOMIC RESEARCH, 2008, 18 (Suppl 1) : 14 - 18
  • [27] Visceral orthostatic hypotension in patients with severe autonomic dysfunction
    Terazaki, H
    Ando, Y
    Yamashita, T
    Obayashi, K
    Nakamura, K
    Nakamura, M
    Yoshimatsu, S
    Suga, M
    Uchino, M
    Ando, M
    JOURNAL OF THE AUTONOMIC NERVOUS SYSTEM, 1998, 68 (1-2): : 101 - 108
  • [28] Neurogenic orthostatic hypotension: New prospects in treatment
    Kaufmann, Horacio
    CLINICAL AUTONOMIC RESEARCH, 2008, 18 (Suppl 1) : 1 - 1
  • [29] Neurogenic orthostatic hypotension: New prospects in treatment
    Horacio Kaufmann
    Clinical Autonomic Research, 2008, 18 : 1 - 1
  • [30] Pyridostigmine in the treatment of orthostatic hypotension
    Jean-Michel Senard
    Clinical Autonomic Research, 2005, 15 : 421 - 422